Table 1.

Effect of GCV treatment on pathology scores in recipients of IL-2-tk spleen cells

OrganGroup
BM (PBS) (2)BM (GCV) (2)Tg (PBS) (1)Tg (GCV) (5)IL-2-tk (PBS) (9)IL-2-tk (GCV) (11)
Liver 0.5 ± 0.7 0.5 ± 0.7 2 ± 0 2 ± 0.8 2 ± 0.4 1 ± 0.7 
Colon 0 ± 0 0 ± 0 3 ± 0 3 ± 0.5 2 ± 0.4 1 ± 0.7* 
Small intestine 1.5 ± 0.7 1 ± 0 0 ± 0 2 ± 0.4 1 ± 0.7 2 ± 0.5 
Skin 0 ± 0 0 ± 0 7 ± 0 1 ± 3.7 0 ± 2.2 0 ± 2.2 
Ear 0 ± 0 0 ± 0 8 ± 0 6 ± 3.6 3 ± 2.5 0 ± 2 
Tongue 0 ± 0 0 ± 0 2 ± 0 2 ± 2.2 2 ± 1.4 0 ± 0.9* 
OrganGroup
BM (PBS) (2)BM (GCV) (2)Tg (PBS) (1)Tg (GCV) (5)IL-2-tk (PBS) (9)IL-2-tk (GCV) (11)
Liver 0.5 ± 0.7 0.5 ± 0.7 2 ± 0 2 ± 0.8 2 ± 0.4 1 ± 0.7 
Colon 0 ± 0 0 ± 0 3 ± 0 3 ± 0.5 2 ± 0.4 1 ± 0.7* 
Small intestine 1.5 ± 0.7 1 ± 0 0 ± 0 2 ± 0.4 1 ± 0.7 2 ± 0.5 
Skin 0 ± 0 0 ± 0 7 ± 0 1 ± 3.7 0 ± 2.2 0 ± 2.2 
Ear 0 ± 0 0 ± 0 8 ± 0 6 ± 3.6 3 ± 2.5 0 ± 2 
Tongue 0 ± 0 0 ± 0 2 ± 0 2 ± 2.2 2 ± 1.4 0 ± 0.9* 

Shown are means ± SD of scores from each indicated group. Numbers of mice in each are given in parenthesis after the group name.

*

P < .05.

or Create an Account

Close Modal
Close Modal